Exhibit A
AGREEMENT
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of them of a statement on Schedule 13D (including amendments thereto) with respect to the shares of common stock, $0.001 par value per share, of CytoDyn Inc., a Delaware corporation, and further agree that this Joint Filing Agreement be included as Exhibit A to such Schedule 13D. In evidence thereof, the undersigned hereby execute this agreement this 26th day of November, 2018.
| November 26, 2018 | ||
| (Date)
| ||
| /s/ Richard G. Pestell, M.D., Ph.D. | ||
| Richard G. Pestell, M.D., Ph.D. | ||
| PROSTAGENE, LLC | ||
| By: | /s/ Richard G. Pestell, M.D., Ph.D. | |
| Name: Richard G. Pestell, M.D., Ph.D. | ||
| Title: Chief Executive Officer | ||